The aim of the investigators study is to compare in children aged less than 18 months and hospitalized for an acute viral bronchiolitis the efficacy of the HS 3% (Mucoclear®, sterile ampoules of 4 ml) nebulised with a conventional jet-nebulizer (particles diameter of 4-5 µm), or with a jet-nebulizer adapted for infants (particles diameter of 2-2.5 µm), or with a mesh-nebulizer adapted for infants (particles diameter of 2-2.5 µm).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
168
Assistance Publique Hopitaux de Marseille
Marseille, France
the improvement of the clinical score of severity at the 48th hour between the 3 groups of children
Time frame: 12 months
the number of children requiring oxygen
Time frame: 12 months
tolerance of the nebulisations
Time frame: 12 months
the number of complications.
Time frame: 12 months
the number of parenteral nutrition
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.